RVTY logo

Revvity (RVTY)

Profile

Full Name

Revvity, Inc.

Ticker Symbol

RVTY

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

July 6, 1965

Indexes

S&P 500

Website

http://www.revvity.com

Employees

11000

Key Details

Price

$92.83(-1.23%)

Market cap

Last Dividend

$0.07

TTM Dividend yield

0.30%

Annual revenue

$2.76B(+0.16% YoY)

Annual EPS

$2.20(-60.36% YoY)

PE ratio

39.50

Next earnings date

Jul 29, 2025

Next ex-dividend date

Jul 18, 2025

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$92.83
RVTY price is $92.83

30-Day Relative Volume

0.50
RVTY 30-day relative volume is 0.50

Price Performance

Price Today change

-1.23%
RVTY price is down -1.23% today

Price YTD change

-16.83%
RVTY price is down -16.83% since January 1st

Price 1-year change

-7.73%
RVTY price is down -7.73% year-on-year

Price 3-year change

-37.24%
RVTY price is down -37.24% over the past 3 years

Price Range

Price All-time high

$203.16
RVTY price is currently -54.31% below its historical high of $203.16

Price 3-year low

$79.50
RVTY price is currently +16.77% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.15B
RVTY market capitalization is $11.15 billion

Market cap 3-year change

-40.23%
RVTY market capitalization is down -40.23% over the past 3 years

Market cap All-time high

$25.38B
RVTY market capitalization is currently -56.06% below its historical high of $25.38 billion

Market cap sector rank

93.16%
RVTY market capitalization is higher than 93.16% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.71%
RVTY shares outstanding is down -2.71% year-on-year

Shares Outstanding 3-Year Change

-4.75%
RVTY shares outstanding is down -4.75% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.94
RVTY beta is 0.94

200-day SMA

$114.89
RVTY price is currently -19.20% below its 200-day simple moving average

50-day SMA

$103.56
RVTY price is currently -10.36% below its 50-day simple moving average

RSI

41.10
RVTY 14-day relative strength index is 41.10

Volume

0.50
RVTY 30-day relative volume is 0.50

ATR

$3.98
RVTY average true range is $3.98

10-day Historical Volatility

22.36%
RVTY 10-day historical volatility is 22.36%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.07
RVTY last dividend was $0.07 per share, with an ex-dividend date of April 17, 2025

Next Dividend

$0.07
RVTY has announced a dividend of $0.07 per share, with an ex-dividend date set for July 18, 2025

Dividend per share

Dividend per share

$0.28
RVTY annual dividend per share is $0.28

Dividend per share Sector Rank

16.09%
RVTY annual dividend per share is higher than 16.09% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
RVTY {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

0%
RVTY {parameterFullLabel} has remained unchanged over the past 3 years

Dividend yield

Dividend yield

0.30%
RVTY annual dividend yield is 0.30%

Dividend yield Sector Rank

5.81%
RVTY annual dividend yield is higher than 5.81% of companies in Healthcare sector

Other

Payout ratio

12.74%
RVTY annual payout ratio is 12.74%

Dividends paid

$34.45M
RVTY annual dividends paid is $34.45 million

Free cash flow

$541.65M
RVTY annual free cash flow is $541.65 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.76B
RVTY annual revenue is $2.76 billion

Revenue Analysts estimate

$2.85B
RVTY annual revenue is currently -3.33% lower than the consensus analysts' forecast

Revenue 1-year change

+0.16%
RVTY annual revenue is up +0.16% year-on-year

Revenue Sector rank

87.39%
RVTY annual revenue is higher than 87.39% of companies in Healthcare sector

EPS

EPS

$2.20
RVTY annual earnings per share is $2.20

EPS Analysts estimate

$4.93
RVTY annual earnings per share is currently -55.35% lower than the consensus analysts' forecast

EPS 1-year change

-60.36%
RVTY annual earnings per share is down -60.36% year-on-year

EPS Sector rank

92.6%
RVTY annual earnings per share is higher than 92.6% of companies in Healthcare sector

Profit

Gross profit

$1.54B
RVTY annual gross profit is $1.54 billion

Gross margin

55.81%
RVTY annual gross profit margin is 55.81%

Operating profit

$346.74M
RVTY annual operating income is $346.74 million

Operating margin

12.59%
RVTY annual operating profit margin is 12.59%

Net income

$270.38M
RVTY annual net profit is $270.38 million

Net margin

9.81%
RVTY annual net profit margin is 9.81%

Expenses

Total expenses

$2.41B
RVTY annual total expenses is $2.41 billion

Operating expenses

$1.19B
RVTY annual total operating expenses is $1.19 billion

Cost of goods sold

$1.22B
RVTY annual cost of goods sold is $1.22 billion

Selling, general & administrative expenses

$994.07M
RVTY annual SGA is $994.07 million

Depreciation and amortization

$427.85M
RVTY annual depreciation & amortization is $427.85 million

Interest expense

$96.28M
RVTY annual interest expense is $96.28 million

Income tax

$33.05M
RVTY annual income tax is $33.05 million

EBIT & EBITDA

EBIT

$412.40M
RVTY annual earnings before interest & taxes is $412.40 million

EBITDA

$840.25M
RVTY annual EBITDA is $840.25 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.39B
RVTY annual total assets is $12.39 billion

Non current assets

$10.04B
RVTY annual long term assets is $10.04 billion

Current assets

$2.35B
RVTY annual total current assets is $2.35 billion

Cash and cash equivalents

$1.16B
RVTY annual cash & cash equivalents is $1.16 billion

Accounts receivable

$632.40M
RVTY annual accounts receivable is $632.40 million

Inventory

$367.59M
RVTY annual inventory is $367.59 million

Liabilities

Total liabilities

$4.73B
RVTY annual total liabilities is $4.73 billion

Long term liabilities

$4.07B
RVTY annual total long term liabilities is $4.07 billion

Current liabilities

$653.10M
RVTY annual total current liabilities is $653.10 million

Accounts payable

$167.46M
RVTY annual accounts payable is $167.46 million

Debt

Total debt

$3.33B
RVTY annual total debt is $3.33 billion

Total debt 1-year change

-18.19%
RVTY annual total debt is down -18.19% year-on-year

Long term debt

$3.30B
RVTY annual long term debt is $3.30 billion

Short term debt

$23.82M
RVTY annual short term debt is $23.82 million

Equity & Capital

Shareholders equity

$7.67B
RVTY annual stockholders equity is $7.67 billion

Book value

$7.67B
RVTY annual book value is $7.67 billion

Retained earnings

$5.85B
RVTY annual retained earnings is $5.85 billion

Working capital

$1.70B
RVTY annual working capital is $1.70 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$628.30M
RVTY annual cash flow from operations is $628.30 million

Cash from operations 1-year change

+588.38%
RVTY annual cash flow from operations is up +588.38% year-on-year

Cash from investing

$776.16M
RVTY annual cash flow from investing activities is $776.16 million

Cash from investing 1-year change

-40.91%
RVTY annual cash flow from investing activities is down -40.91% year-on-year

Cash from financing

-$1.13B
RVTY annual cash flow from financing activities is -$1.13 billion

Cash from financing 1-year change

-19.12%
RVTY annual cash flow from financing activities is down -19.12% year-on-year

CAPEX

CAPEX

$86.65M
RVTY annual capital expenditures is $86.65 million

CAPEX 1-year change

+6.49%
RVTY annual capital expenditures is up +6.49% year-on-year

Free Cash Flow

Free cash flow

$541.65M
RVTY annual free cash flow is $541.65 million

Free cash flow 1-year change

+5369.01%
RVTY annual free cash flow is up +5369.01% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.81%
RVTY annual gross profit margin is 55.81%

Operating margin

12.59%
RVTY annual operating profit margin is 12.59%

Net margin

9.81%
RVTY annual net profit margin is 9.81%

ROA & ROE

ROA

2.08%
RVTY annual return on assets is 2.08%

ROE

3.48%
RVTY annual return on equity is 3.48%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

39.50
RVTY price to earnings ratio is 39.50

PE ratio Sector rank

70.79%
RVTY price to earnings ratio is higher than 70.79% of companies in Healthcare sector

PB Ratio

PB ratio

1.46
RVTY price to book ratio is 1.46

PB ratio Sector rank

50.45%
RVTY price to book ratio is higher than 50.45% of companies in Healthcare sector

PS Ratio

PS ratio

4.03
RVTY price to sales ratio is 4.03

PS ratio Sector rank

58.55%
RVTY price to sales ratio is higher than 58.55% of companies in Healthcare sector

Enterprise value

Enterprise value

$13.34B
RVTY enterprise value is $13.34 billion

Enterprise value Sector rank

93.92%
RVTY enterprise value is higher than 93.92% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

15.76
RVTY EV/EBITDA is 15.76

EV/EBITDA Sector rank

89.35%
RVTY EV/EBITDA is higher than 89.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.60
RVTY annual current ratio is 3.60

Quick ratio

3.03
RVTY annual quick ratio is 3.03

Leverage

Debt to equity

0.41
RVTY annual debt to equity ratio is 0.41

Interest coverage ratio

4.28
RVTY annual interest coverage ratio is 4.28

Risk & Stability

Piotroski F-Score

8
RVTY piotroski f-score is 8

Altman Z-Score

2.57
RVTY altman z-score is 2.57

Analyst ratings

Recent major analysts updates

May 1, 25 UBS
Buy
Apr 29, 25 Raymond James
Outperform
Apr 29, 25 JP Morgan
Neutral
Apr 29, 25 Goldman Sachs
Buy
Apr 29, 25 Baird
Outperform
Apr 21, 25 Baird
Outperform
Apr 17, 25 Wells Fargo
Equal-Weight
Apr 10, 25 Barclays
Overweight
Feb 3, 25 Raymond James
Outperform
Feb 3, 25 Keybanc
Overweight

Institutional Ownership

Similar stocks

EXEL logo
Exelixis (EXEL)
DOCS logo
Doximity (DOCS)
DVA logo
DaVita (DVA)
PEN logo
Penumbra (PEN)
NBIX logo
Neurocrine Biosciences (NBIX)
ICLR logo
ICON Public Limited (ICLR)
MRNA logo
Moderna (MRNA)
RDY logo
Dr Reddys Laboratories Limited (RDY)
SOLV logo
Solventum (SOLV)
  • What is the ticker symbol for Revvity?
  • Does Revvity pay dividends?
  • What sector is Revvity in?
  • What industry is Revvity in?
  • What country is Revvity based in?
  • When did Revvity go public?
  • Is Revvity in the S&P 500?
  • Is Revvity in the NASDAQ 100?
  • Is Revvity in the Dow Jones?
  • When was Revvity's last earnings report?
  • When does Revvity report earnings?
  • Should I buy Revvity stock now?

What is the ticker symbol for Revvity?

The ticker symbol for Revvity is NYSE:RVTY

Does Revvity pay dividends?

Yes, Revvity pays dividends. The last payment was $0.07, with an ex-dividend date on April 17, 2025

What sector is Revvity in?

Revvity is in the Healthcare sector

What industry is Revvity in?

Revvity is in the Diagnostics & Research industry

What country is Revvity based in?

Revvity is headquartered in United States

When did Revvity go public?

Revvity's initial public offering (IPO) was on July 6, 1965

Is Revvity in the S&P 500?

Yes, Revvity is included in the S&P 500 index

Is Revvity in the NASDAQ 100?

No, Revvity is not included in the NASDAQ 100 index

Is Revvity in the Dow Jones?

No, Revvity is not included in the Dow Jones index

When was Revvity's last earnings report?

Revvity's most recent earnings report was on Apr 28, 2025

When does Revvity report earnings?

The next expected earnings date for Revvity is Jul 29, 2025

Should I buy Revvity stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page